Literature DB >> 20819308

Gene cloning, expression and serological evaluation of the 12-kDa antigen-B subunit from Echinococcus granulosus.

J Abdi1, B Kazemi, M Mohebali, M Bandehpour, M T Rahimi, M B Rokni.   

Abstract

A 12-kDa subunit of antigen B from Echinococcus granulosus has recently been cloned, expressed and used in diagnostic ELISA to test human sera for evidence of cystic echinococcosis. The performance of the ELISA based on the recombinant antigen (rAgB) was compared with that of similar assays based on native antigen B (nAgB) or hydatid-cyst fluid. For the preparation of the rAgB, total RNA was extracted from Ec. granulosus protoscoleces so that antigen-B complementary DNA could be synthesised, amplified by PCR, and then cloned into the pQE30 expression vector. The recombinant plasmid was transformed in Escherichia coli and induced using isopropyl-beta-D-thiogalactopyrano-side. Bacterial samples were collected, lysed and then analysed by SDS-PAGE and western blotting. The recombinant protein was purified by affinity chromatography. Although the performance of the ELISA based on cyst fluid appeared identical to that of the assay based on the recombinant antigen (with a sensitivity, specificity, positive predictive value and negative predictive value of 96.0%, 97.0%, 97.2% and 95.5%, respectively), the corresponding results for the ELISA based on nAgB (98.6%, 100%, 100% and 98.5%) were slightly better. Despite this difference (which was not statistically significant), the comparative ease with which large quantities of the recombinant antigen could be produced make the antigen a potentially useful tool in the diagnosis of cystic echinococcosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819308     DOI: 10.1179/136485910X12743554760261

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  8 in total

Review 1.  Immunodiagnosis of human hydatid disease: Where do we stand?

Authors:  Bahador Sarkari; Zahra Rezaei
Journal:  World J Methodol       Date:  2015-12-26

2.  A Study of Cross-Reactivity Between Recombinant EPC1 Antigen of Echinococcus granulosus in Serum from Patients with Confirmed Cystic Echinococcosis Infection and Other Parasitic Infections.

Authors:  Saeid Fathi; Fatemeh Jalousian; Seyed Hossein Hosseini; Hossein Parsa; Somayeh Kordafshari
Journal:  Am J Trop Med Hyg       Date:  2016-04-18       Impact factor: 2.345

3.  Serological Evaluation of EgAgB16 kDa, a Recombinant Antigen from Echinococcus granulosus for Diagnosis of Human Hydatidosis.

Authors:  J Abdi; B Kazemi; A Haniloo; M Mohebali; M Mahmoudi; S Rezaei; M Bandehpour; L Maghen; Mb Rokni
Journal:  Iran J Parasitol       Date:  2010-09       Impact factor: 1.012

4.  Echinococcosis/Hydatidosis in ilam province, Western iran.

Authors:  Jahangir Abdi; Morovat Taherikalani; Kheirolah Asadolahi; Mohammad Emaneini
Journal:  Iran J Parasitol       Date:  2013-07       Impact factor: 1.012

5.  Molecular Cloning, Expression and Characterization of Plasmid Encoding Rhomboid 4 (ROM4) of Tachyzoite of Toxoplasma gondii RH Strain.

Authors:  Mohammad Taghi Rahimi; Shahabeddin Sarvi; Mahdi Sharif; Saeid Abediankenari; Ehsan Ahmadpour; Reza Valadan; Ahmad Daryani
Journal:  Iran J Parasitol       Date:  2017 Oct-Dec       Impact factor: 1.012

6.  Genotyping of Hydatid Cyst Isolated from Human and Domestic Animals in Ilam Province, Western Iran Using PCR-RFLP.

Authors:  M Dousti; J Abdi; S Bakhtiyari; M Mohebali; Sh Mirhendi; Mb Rokni
Journal:  Iran J Parasitol       Date:  2013-01       Impact factor: 1.012

7.  Molecular Cloning and Expression an 8-kDa Subunit of Antigen B from G1 strain of Echinococcus granulosus.

Authors:  Hakim Azizi; Bahram Kazemi; Mojgan Bandehpour; Mehdi Mohebali; Ali Khamesipour; Mojgan Aryaeipour; Mohammad Bagher Rokni
Journal:  Iran J Public Health       Date:  2015-07       Impact factor: 1.429

8.  Expansion of a highly sensitive and specific ELISA test for diagnosis of hydatidosis using recombinant EgB8/2 protein.

Authors:  Sareh Bashiri; Fahimeh Nemati Mansoor; Zarrintaj Valadkhani
Journal:  Iran J Basic Med Sci       Date:  2019-02       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.